Company filings profile · CIK 0001091596
Nuo Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Nuo Therapeutics, Inc. (AURX): 6 filings in the last 90 days vs 12 in the prior 90 (filing-velocity cooling ↓ · 0.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 7, 2026. Source-linked, daily-refreshed.
Material 8-K events — Nuo Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 6, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 17, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 3, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jan 26, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Dec 17, 2025 | Item 5.07 | ↗ |
| Oct 10, 2025 | Departure/Election of Directors or Officers; Item 5.08; Other Events | ↗ |
Watch Nuo Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 6, 2026 | 4 | FORM 4 - SCOTT PITTMAN - SECOND FUNDING WARRANTS | ↗ |
| Oct 6, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 31, 2026 | 4/A | FORM 4/A | ↗ |
| Aug 28, 2026 | 4 | FORM 4 | ↗ |
| Aug 17, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | 10-Q | FORM 10-Q | ↗ |
| Jul 2, 2026 | 4 | FORM 4 | ↗ |
| Jul 2, 2026 | 4 | FORM 4 | ↗ |
| Jul 2, 2026 | 4 | FORM 4 | ↗ |
| Jul 2, 2026 | 4 | FORM 4 | ↗ |
| Jul 2, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 3, 2026 | SCHEDULE 13D/A | ↗ | |
| Jun 3, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 2, 2026 | 4 | FORM 4 | ↗ |
| Jun 2, 2026 | 4/A | FORM 4/A | ↗ |
| May 14, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 14, 2026 | 10-Q | FORM 10-Q | ↗ |
| Mar 30, 2026 | 10-K | FORM 10-K | ↗ |
| Feb 12, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 26, 2026 | 4 | FORM 4 | ↗ |
| Jan 26, 2026 | SCHEDULE 13D/A | ↗ | |
| Jan 26, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jan 5, 2026 | 4 | FORM 4 | ↗ |
| Dec 22, 2025 | 4 | FORM 4 | ↗ |
| Dec 17, 2025 | 8-K | Item 5.07 | ↗ |
| Dec 11, 2025 | 4/A | FORM 4/A | ↗ |
| Dec 11, 2025 | 4 | FORM 4 | ↗ |
| Dec 3, 2025 | 4 | FORM 4 - NOVEMBER 2025 PRIVATE SALE | ↗ |
| Oct 30, 2025 | 10-Q | FORM 10-Q | ↗ |
| Oct 30, 2025 | DEFA14A | FORM DEFA14A | ↗ |
| Oct 30, 2025 | DEF 14A | FORM DEF 14A | ↗ |
| Oct 10, 2025 | 8-K | Departure/Election of Directors or Officers; Item 5.08; Other Events | ↗ |
| Aug 4, 2025 | D | Item 06b | ↗ |
| Aug 4, 2025 | 4/A | FORM 4/A | ↗ |
| Aug 4, 2025 | 4 | FORM 4 | ↗ |
| Aug 4, 2025 | 4 | FORM 4 | ↗ |
| Aug 4, 2025 | 4 | FORM 4 | ↗ |
| Aug 4, 2025 | 4 | FORM 4 | ↗ |
| Aug 1, 2025 | 4 | FORM 4 | ↗ |